Competition will intensify for the $740 million minimally invasive spinal fusion market over the next few years as more companies challenge industry leaders NuVasive and Medtronic Spinal & Biologics, according to a Millennium Research Group report.
NuVasive was the only major spine company in the U.S. to continue to post double-digit revenue growth in 2010 because of its success with the extreme lumbar interbody fusion procedure, the first lateral approach to spine surgery.
More companies are now presenting a challenge to NuVasive, as DePuy Spine launched the COUGAR LS and PIPELINE LS lateral spine systems, K2M launched its RAVINE lateral access system and Globus Medical launched its TransContinental Spacer in 2010. The minimally invasive spinal fusion market is still plagued by scrutiny for lumbar fusion approval by private payors and pricing pressures that have softened the overall spine market growth.
Patent infringement lawsuits will also impact the sales in the minimally invasive spinal fusion market because the focus will shift away from research and development of these products.
Read the Millennium Research Group release on the minimally invasive spinal fusion market.
Read other coverage on new spine systems:
- DePuy Spine Launches New Systems at NASS Annual Meeting
- K2M Launches Lateral Access Spinal System
- NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
NuVasive was the only major spine company in the U.S. to continue to post double-digit revenue growth in 2010 because of its success with the extreme lumbar interbody fusion procedure, the first lateral approach to spine surgery.
More companies are now presenting a challenge to NuVasive, as DePuy Spine launched the COUGAR LS and PIPELINE LS lateral spine systems, K2M launched its RAVINE lateral access system and Globus Medical launched its TransContinental Spacer in 2010. The minimally invasive spinal fusion market is still plagued by scrutiny for lumbar fusion approval by private payors and pricing pressures that have softened the overall spine market growth.
Patent infringement lawsuits will also impact the sales in the minimally invasive spinal fusion market because the focus will shift away from research and development of these products.
Read the Millennium Research Group release on the minimally invasive spinal fusion market.
Read other coverage on new spine systems:
- DePuy Spine Launches New Systems at NASS Annual Meeting
- K2M Launches Lateral Access Spinal System
- NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical